Your Article Summary
See Latest ArticlesImpact of serum caffeine monitoring on adverse effects and chemotherapeutic responses to caffeine-potentiated chemotherapy for osteosarcoma
Journal of Orthopaedic Science, 06/10/09
Hayashi K et al. - In a trial to assess the use of monitoring and adjusting serum caffeine levels during caffeine-potentiated chemotherapy to reduce adverse effects it was concluded that monitoring and adjusting caffeine levels were achieved without apparent loss of chemotherapeutic efficacy.
Methods- A method for rapidly determining caffeine concentration by high-performance liquid chromatography was utilized.
- The maximum caffeine concentration was predicted from the measured concentrations at 24 and 48 hr after the beginning of caffeine administration.
- Caffeine infusion rate was then modified accordingly to prevent the expected final concentration from exceeding 80 ?g/ml.
- The study involved 22 American Joint Committee on Cancer (AJCC) stage IIB high-grade osteosarcoma pts treated with caffeine-potentiated chemotherapy.
- 9 pts underwent monitoring of their serum caffeine levels (monitoring group), and the remaining 13 pts were not monitored (nonmonitoring group).
- Toxicities were graded according to the Japan Clinical Oncology Group Toxicity Criteria.
- Hematological toxic events were well tolerated in both groups.
- Grade 4 leukocyte toxicity events occurred in both groups.
- In the nonmonitoring group, grade 2 or higher toxicities included 5 elevated aspartate aminotransferase/alanine aminotransferase level events and 17 hyponatremia events vs 1 hyponatremia event in the monitoring group.
- Histological examination of excised tumor samples after preoperative chemotherapy revealed that chemotherapeutic efficacy in the monitoring group was as good as in the nonmonitoring group.
- Median follow-up period in all pts was 72 mos.
- Event-free survival was 76%, and overall survival was 100%.
Related Articles
The role of interferons in the treatment of osteosarcoma
Pediatric Blood & Cancer, 11/12/09
Relevance Score: 88%
Reconstruction Using a Frozen Bone Method for Osteosarcoma of the Talus. A Case Report and Review of the Literature
Anticancer Research, 11/11/09
Relevance Score: 88%
Profiling of high-grade central osteosarcoma and its putative progenitor cells identifies tumourigenic pathways
British Journal of Cancer, 11/06/09
Relevance Score: 88%
Synchronous and metachronous skeletal osteosarcomas: The Norwegian Radium Hospital experience
Acta Oncologica, 10/26/09
Relevance Score: 88%
Tumoral Calcinosis Mimicking Recurrent Osteosarcoma
Radiology Case Reports, 10/23/09
Relevance Score: 88%
Today in Bone/Cartilage...keeping you current
Receive free subspecialty "5-minute updates" via email
mTOR/p70S6K Signal transduction pathway contributes to osteosarcoma progression and patients prognosis
Medical Oncology, 12/04/09
Oleanolic acid derivative Dex-OA has potent anti-tumor and anti-metastatic activity on osteosarcoma cells in vitro and in vivo
Investigational New Drugs, 12/04/09
Interventional radiology procedures in the treatment of bone metastasis
Bulletin du Cancer, 12/01/09